State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Состояние лечения сахарного диабета 1 типа и исходы по данным регистра T1D Exchange в 2016–2018 годах
2019-01-18
SCID: 54.1/682fsgdd
Discuss with AI
Continuous glucose monitoringHbA1c outcomesInsulin pump useT1D Exchange registryType 1 diabetes
Figures from the paper
Abstract (AI)
OBJECTIVE: To provide a snapshot of the profile of adults and youth with type 1 diabetes (T1D) in the United States and assessment of longitudinal changes in T1D management and clinical outcomes in the T1D Exchange registry. RESEARCH DESIGN AND METHODS: Data on diabetes management and outcomes from 22,697 registry participants (age 1-93 years) were collected between 2016 and 2018 and compared with data collected in 2010-2012 for 25,529 registry participants. RESULTS: Mean HbA1c in 2016-2018 increased from 65 mmol/mol at the age of 5 years to 78 mmol/mol between ages 15 and 18, with a decrease to 64 mmol/mol by age 28 and 58-63 mmol/mol beyond age 30. The American Diabetes Association (ADA) HbA1c goal of <58 mmol/mol for youth was achieved by only 17% and the goal of <53 mmol/mol for adults by only 21%. Mean HbA1c levels changed little between 2010-2012 and 2016-2018, except in adolescents who had a higher mean HbA1c in 2016-2018. Insulin pump use increased from 57% in 2010-2012 to 63% in 2016-2018. Continuous glucose monitoring (CGM) increased from 7% in 2010-2012 to 30% in 2016-2018, rising >10-fold in children <12 years old. HbA1c levels were lower in CGM users than nonusers. Severe hypoglycemia was most frequent in participants ≥50 years old and diabetic ketoacidosis was most common in adolescents and young adults. Racial differences were evident in use of pumps and CGM and HbA1c levels. CONCLUSIONS: Data from the T1D Exchange registry demonstrate that only a minority of adults and youth with T1D in the United States achieve ADA goals for HbA1c.
Key Findings
1
Among 22,697 U.S. registry participants in 2016–2018, mean HbA1c peaked at 78 mmol/mol among adolescents aged 15–18 years.
2
CGM users had lower HbA1c levels than nonusers, while severe hypoglycemia was most frequent in adults aged 50 years or older and diabetic ketoacidosis in adolescents and young adults.
3
Insulin pump use increased from 57% to 63%, and CGM use increased from 7% to 30%; CGM use rose more than tenfold among children younger than 12 years.
4
Mean HbA1c changed little from 2010–2012 to 2016–2018, except for higher levels among adolescents in the later period.
5
Only 17% of youth achieved the ADA HbA1c goal below 58 mmol/mol, while 21% of adults achieved the goal below 53 mmol/mol.
6
Racial differences were observed in insulin pump and CGM use and in HbA1c levels.
Research Object
Adults and youth with type 1 diabetes in the United States enrolled in the T1D Exchange registry
Research Subject
Longitudinal patterns and racial and age-related differences in diabetes management and clinical outcomes, including HbA1c, insulin pump and CGM use, severe hypoglycemia, and diabetic ketoacidosis
Publication Details
Publication Date
2019-01-18
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai2
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus1993
Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes2017